Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.21+0.18 (+5.94%)
Close on Nov 13, 2026Market cap $12.68MP/E –Yield –
Onconetix operating margin
Operating margin is operating income as a percentage of revenue.
Onconetix's operating margin for the twelve months ending Jun 30, 2026 was -2525.0%. For fiscal 2025 it was -2190.0%, against -2238.0% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2190.0% | +47.9 |
| FY2024 | Dec 31, 2024 | -2238.0% | +59396.5 |
| FY2023 | Dec 31, 2023 | -61634.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -15950.9% | −14133.5 |
| Q1 FY2026 | Mar 31, 2026 | -47657.2% | −35288.0 |
| Q4 FY2025 | Dec 31, 2025 | -422.1% | +3671.6 |
| Q3 FY2025 | Sep 30, 2025 | -681.5% | −31.1 |
| Q2 FY2025 | Jun 30, 2025 | -1817.4% | +114.2 |
| Q1 FY2025 | Mar 31, 2025 | -12369.2% | −10787.0 |
| Q4 FY2024 | Dec 31, 2024 | -4093.7% | – |
| Q3 FY2024 | Sep 30, 2024 | -650.3% | – |
| Q2 FY2024 | Jun 30, 2024 | -1931.6% | – |
| Q1 FY2024 | Mar 31, 2024 | -1582.2% | – |
See a number that looks wrong?